JARZEPAM

This brand name is authorized in Nigeria.

Active ingredients

The drug JARZEPAM contains one active pharmaceutical ingredient (API):

1	Diazepam UNII Q3JTX2Q7TU - DIAZEPAM
	Diazepam is a psychotropic substance from the class of 1,4-benzodiazepines with marked properties of suppression of tension, agitation and anxiety as well as sedative and hypnotic effects. In addition, diazepam demonstrates muscle relaxant and anticonvulsive properties. It is used in the short-term treatment of anxiety and tension states, as a sedative and premedicant, in the control of muscle spasm and in the management of alcohol withdrawal symptoms.
	Read more about Diazepam

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-4587	Injection	Jarzepam Injection INJ 10 mg/2 mL	JARZEPAM INJECTION B4-4587 JARZEPAM INJECTION diazepam bp 10mg/2ml,benzyl alcohol 2% Prescription Only Medicine (POM) CURAMUS HELT LIMITED, UCHE OKONKWO STREET, ASABA. DELTA SWISS PARENTERALS LTD, 809, KERALA GIDC NR. BARLA DIST. AHMEDABAD, 382220 GUJURAT, INDIA, India 23/02/2023 22/02/2028	23/02/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N05BA01	Diazepam	N Nervous system → N05 Psycholeptics → N05B Anxiolytics → N05BA Benzodiazepine derivatives
Discover more medicines within N05BA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-4587